Buscar
-
Trends in use of benzodiazepines and Z-drugs in France from 2012 to 2020
(Therapies, 2022-12-09)Article de revue -
Will the future of pharmacovigilance be more automated?
(Expert Opinion on Drug Safety. vol. 22, n° 7, pp. 541-548, 2023-07-01)Article de revue -
Bidisciplinary dermatology-pharmacovigilance consultations: Results of a two-year study
(Annales de Dermatologie et de Vénéréologie, 2022-12-07)Article de revue -
Role of spontaneous reporting in investigating the relationship between mRNA COVID-19 vaccines and myocarditis: The French perspective
(Therapies, 2023-03-07)Article de revue -
Pharmacovigilance signals from active surveillance of mRNA platform vaccines (tozinameran and elasomeran)
(Therapies, 2023-03-11)Article de revue -
Use of psychotropic drugs in the elderly in France: Are we condemned to remain at high tide?
(Therapies, 2023-03-15)Article de revue -
Bleeding risk with concurrent use of anticoagulants and ibrutinib: A population-based nested case-control study
(British Journal of Haematology. vol. 203, n° 2, pp. 311-318, 2023-10-01)Article de revue -
Drug-Drug Interactions and the Risk of Emergency Hospitalizations: A Nationwide Population-Based Study
(Drug Safety. vol. 46, n° 5, pp. 449-456, 2023-05)Article de revue -
Response to Comment on Bezin et al. GLP-1 Receptor Agonists and the Risk of Thyroid Cancer. Diabetes Care 2023;46:384-390
(Diabetes Care. vol. 46, n° 5, pp. e121-e122, 2023-05-01)Article de revue -
The ongoing structuring of human papillomavirus (HPV) vaccination in middle schools in Nouvelle-Aquitaine, France
(Infectious Diseases Now. vol. 53, n° 5, pp. 104717, 2023-05-04)Article de revue